Success for MIMS Android and iPhone apps
With more than 10,000 downloads and a 4-star rating, the MIMS applications...
Jump to:
The MIMS Consultation Guide is a new clinical reference book from the publishers of MIMS and GP magazine. This comprehensive resource provides more than 260 pages of quick-reference material, organised into A-Z sections covering all aspects of a typical patient consultation.
Vismodegib is set to be the first targeted treatment for basal cell...
With more than 10,000 downloads and a 4-star rating, the MIMS applications...
Sycrest (asenapine) is a new atypical antipsychotic licensed for the treatment of...
A new NNRTI, rilpivirine, has been launched as both a single component...
Following the publication of guidance by the National Patient Safety Agency on...
Botox (botulinum toxin) has been licensed for the temporary improvement of moderate...
The licence for the Pfizer pneumococcal conjugate vaccine, Prevenar 13, has been...
Following an appeal from the manufacturer, NICE has published a final technology...
The following products are no longer available and have been removed from...
The following products have become available for the UK market in 2012....
A new treatment for antibiotic-associated diarrhoea is set to be approved within...
Buccal midazolam is now available as a licensed product (Buccolam) for paediatric...
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.